HighCape Capital
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO
Geographical Focus
United States
Industries Focus
- Healthcare
- Medical Devices
- Biotechnology
- Connected Health
Investor Details Founded: 2013
HighCape Capital is a growth equity firm established in 2013, dedicated to supporting innovative life sciences companies as they transition from early stages to successful enterprises. The firm leverages the extensive experience of its team in founding, financing, and leading life sciences companies across various industry segments.
HighCape Capital focuses on providing strategic guidance and operational support to its portfolio companies, fostering entrepreneurship and delivering value to its partners and the healthcare system. The firm's investment areas include connected health, medical devices, and biotechnology.
The HighCape team comprises industry veterans with at least 25 years of experience in the global life sciences industry. They collaborate closely with management teams to enhance commercial and operational strategies, offering hands-on support to ensure the success of each portfolio company.
Requirements
- Innovative life sciences companies in connected health, medical devices, and biotechnology sectors
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Wellinks
- TELA Bio
- Cybrexa Therapeutics
- Alphina Therapeutics
- Modifi BioSciences
- Quantum-Si
- Aziyo Biologics
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$49.95
-
$14.95
-
$39.95
-
$95.00
-
$99.00
-
$299.00
Claim this Investor
Are you an official representative of HighCape Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim